A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Fudan University
Sunnybrook Health Sciences Centre
University Medical Center Groningen
Sun Yat-sen University
Massachusetts General Hospital
Centre Georges Francois Leclerc
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Institut Mutualiste Montsouris
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Infinity Pharmaceuticals, Inc.
Peking Union Medical College Hospital
The Affiliated Hospital of Qingdao University
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Western Sydney Local Health District
Betta Pharmaceuticals Co., Ltd.
RenJi Hospital
Rutgers, The State University of New Jersey
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Jules Bordet Institute
Institut Bergonié
Chinese University of Hong Kong
Affiliated Hospital of Jiangnan University
Trans Tasman Radiation Oncology Group
University of Leeds
University College, London
Sohag University
Jiangsu HengRui Medicine Co., Ltd.
Weprom
Hospices Civils de Lyon
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Peking Union Medical College Hospital
St. Joseph's Healthcare Hamilton
Centre Hospitalier Universitaire de Besancon
Herlev and Gentofte Hospital
Fudan University
Radboud University Medical Center
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Universitätsmedizin Mannheim
Shanghai Junshi Bioscience Co., Ltd.
Tianjin Medical University Second Hospital
Hamilton Health Sciences Corporation
I.M. Sechenov First Moscow State Medical University
Tianjin Medical University Second Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School